Welcome to the Hatter
The Hatter Cardiovascular Institute was founded by Professor Derek Yellon in the late 1990s to investigate the therapeutic potential of ischaemic preconditioning and other novel therapies for ischaemic heart disease.
The Institute is part of the Institute of Cardiovascular Sciences of University College London and continues to lead research in the areas of ischaemia reperfusion injury, cardioprotection and cardiac mitochondrial function and dysfunction.
The Hatter Cardiovascular Institute is a truly translational centre: we take treatments from the experimental basic science stage in our laboratories through to treating patients in the clinic. We are fortunate to have within UCL a range of world-class clinical cardiovascular services through which to recruit patients for trials.
One of the great successes of the institute has been driving forward the clinical application of ischaemic preconditioning to protect the heart against reperfusion injury during heart attacks, work pioneered by Professor Yellon, and which continues to benefit patients today.